Cosentyx unoready 300 MG pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FP1TN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,580
Award facts
- Contract value 100% obligated
- $32,580.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 29, 2026, for the supply of Cosentyx (secukinumab) 300 mg pen injections, 2 ml formulation, with a contract ceiling value of $32,580.04. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is located in Conshohocken, Pennsylvania, which serves as the corporate headquarters for AmerisourceBergen Drug Corp. The contract is due for completion by January 30, 2026.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at up to $999,999,999.00 and extending through December 2026. This comprehensive IDC enables the pharmaceutical distributor to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs globally, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., which maintains the parent IDC relationship with DLA valued at up to $999,999,999.00 through December 2031. The award reflects AmerisourceBergen's established capability to fulfill federal medical procurement requirements through open competition across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FP1TN?
SPE2DR26FP1TN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FP1TN worth?
The government has obligated $32,580 on SPE2DR26FP1TN.
Is contract SPE2DR26FP1TN an order under another contract?
Yes. SPE2DR26FP1TN is a delivery order under SPE2DR25D3014, an indefinite delivery contract.
Was contract SPE2DR26FP1TN competed?
The extent of competition for SPE2DR26FP1TN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award